(Q38168199)

English

Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered

scientific article published on 02 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered (English)

1 reference

Europe PubMed Central

30 August 2017

acute coronary syndrome

1 reference

based on heuristic

inferred from title

author name string

Michael V Cohen

1

1 reference

Europe PubMed Central

30 August 2017

James M Downey

2

1 reference

Europe PubMed Central

30 August 2017

publication date

2 December 2013

1 reference

Europe PubMed Central

30 August 2017

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

30 August 2017

19

1 reference

Europe PubMed Central

30 August 2017

2

1 reference

Europe PubMed Central

30 August 2017

179-190

1 reference

Europe PubMed Central

30 August 2017

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Myocardial salvage in acute myocardial infarction--challenges in clinical translation

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI: Insights from the Zwolle acute myocardial infarction registry

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Update on acute coronary syndromes: the pathologists' view

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Platelet induced aggravation of acute ischaemia in an isolated rabbit heart model

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Impaired platelet function reduces myocardial infarct size in Galphaq knock-out mice in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Platelets activated by collagen through the immunoreceptor tyrosine-based activation motif in the Fc receptor gamma-chain play a pivotal role in the development of myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angiop

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in plat

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in My

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Intravenous platelet blockade with cangrelor during PCI.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Platelet inhibition with cangrelor in patients undergoing PCI.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Universal definition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effect of platelet inhibition with cangrelor during PCI on ischemic events

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Current state of clinical translation of cardioprotective agents for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Postconditioning the human heart

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Ischemic postconditioning: from receptor to end-effector

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Protection from AMP 579 can be added to that from either cariporide or ischemic preconditioning in ischemic rabbit heart

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Door-to-balloon time and mortality among patients undergoing primary PCI.

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1177%2F1074248413508465

21 January 2018

Identifiers

10.1177/1074248413508465

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38168199&oldid=1745379305"